These innovative therapies , Semaglutide , represent a significant advancement in treating metabolic dysfunction and potentially other ailments . These drugs are classified as GLP-1 pathway activators , meaning these substances to emulate the body's GLP-1 peptide, enhancing metabolic secretion an